“Needle-free” COVID-19 Vaccine Solution and Pandemic Preparedness Tool

• PharmaJet Inc. is a Golden, CO based medical device company that has developed and commercialized the most versatile vaccine and therapeutic delivery systems on the market today.
• PharmaJet’s manufacturing is 100% domestic and is currently supplying its products globally to aid in the polio eradication initiative, as well as over 50 vaccine and therapeutic development programs including COVID-19.
• PharmaJet is currently working with over 10 (and growing) novel COVID-19 development programs in the DNA and RNA vaccine and therapeutic area in addition to expanding manufacturing capacity of our delivery technology.
• PharmaJet is currently preparing multiple proposals to BARDA (at their request) for progressing the needle free device as a delivery device to SARS-COV2 vaccines. The proposals will give PharmaJet the ability to deliver up to 50 million doses either with the Stratis Intramuscular administration system or the Tropis Intradermal administration system. Tropis also has the potential to provide antigen sparing which is so important in pandemic vaccine response.
• The devices are commercialized and have been successfully deployed in vaccination campaigns where up to 500,000 children have been vaccinated in 5 days. The observed benefits included 18% more participation, and 99% patient and caregiver approval — all of which lends itself to an effective mass immunization tool. https://www.sciencedirect.com/science/article/pii/S0264410X19317232